Effects of pregabalin on the activity of glutamate transporter type 3
Authors:
- P.B. LeePLP.B. Lee
- J.H. KimJKJ.H. Kim
- S.H. DoSDS.H. Do
- C.S. KimCKC.S. Kim
- 1 August 2012
- journal article
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 109 (2) , 234-239
Abstract
Pregabalin, (S)-3-aminomethyl-5-methyl hexanoic acid, is a ligand for the α2δ subunit (a component of voltage-gated calcium channels) and has analgesic and anticonvulsant properties. Glutamate uptake by glutamate transporters may be a mechanism for these properties. We investigated the effects of pregabalin on the activity of the neuronal glutamate transporter type 3 (EAAT3). EAAT3 was expressed in Xenopus laevis oocytes. Two-electrode voltage clamping was used to record membrane currents before, during, and after applying l-glutamate (30 μM) in the presence or absence of pregabalin. Currents were also measured in oocytes pretreated with a protein kinase C (PKC) activator (phorbol-12-myristate-13-acetate, PMA), PKC inhibitors (chelerythrine or staurosporine), or a phosphatidylinositol-3-kinase (PI3K) inhibitor wortmannin. The exposure of the oocytes injected with EAAT3 mRNA to serial concentrations of pregabalin (0.06-60 μM) significantly increased their responses to 30 μM l-glutamate. A kinetic study showed that pregabalin significantly increased V(max) without changing K(m). Treatment of oocytes with PMA, pregabalin, or pregabalin plus PMA significantly increased transporter currents vs controls, but treatment with PMA plus pregabalin did not increase the responses further vs PMA or pregabalin alone. In addition, pretreatment of oocytes with two PKC inhibitors (chelerythrine or staurosporine), or inhibitor wortmannin, significantly reduced basal and pregabalin-enhanced EAAT3 activity. Pregabalin increased EAAT3 activity and PKC and PI3K were involved. This may explain the analgesic effect of pregabalin in neuropathic pain.Keywords
This publication has 41 references indexed in Scilit:
- Pregabalin as a neuroprotector after spinal cord injury in ratsEuropean Spine Journal, 2008
- Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers †British Journal of Anaesthesia, 2007
- Pregabalin: A novel γ-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disordersClinical Therapeutics, 2007
- Pregabalin action at a model synapse: Binding to presynaptic calcium channel α2-δ subunit reduces neurotransmission in miceEuropean Journal of Pharmacology, 2006
- A study comparing the actions of gabapentin and pregabalin on the electrophysiological properties of cultured DRG neurones from neonatal ratsBMC Pharmacology, 2004
- Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortexNeuropharmacology, 2002
- Upregulation of γ-aminobutyric acid transporter expression: role of alkylated γ-aminobutyric acid derivativesBiochemical Society Transactions, 2001
- Gabapentin inhibits the substance P-facilitated K+-evoked release of [3H]glutamate from rat caudal trigeminal nucleus slicesPain, 2001
- Inhibition of K+-evoked glutamate release from rat neocortical and hippocampal slices by gabapentinNeuroscience Letters, 2000
- Inhibition of uptake, steady‐state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugsBritish Journal of Pharmacology, 1999